Guangxun Gao - Concepedia

Author

Guangxun Gao

Xijing Hospital ORCID

Also Known As

G Gao, G X Gao, G. GAO, Gao Guangxun, Gao, Guangxun, Guang-Xun Gao, Guang-xun Gao, Guangxun Gao, Tadakazu Kondo

155

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Xijing Hospital Air Force Medical University Chinese Academy of Medical Sciences & Peking Union Medical College New York University Hebei Medical University

About

Guangxun Gao is an author at Xijing Hospital specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	361
2	Engineering	1	1	46
3	Health Sciences	1	1	33
4	Natural Sciences	1	1	17
5	Public Health	1	1	33

Guangxun Gao

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies Jingwen Si, Xiangjun Shi, Shuhao Sun, Cancer Cell	2020	174
Targeting Autophagy Augments <i>In Vitro</i> and <i>In Vivo</i> Antimyeloma Activity of DNA-Damaging Chemotherapy Yaozhu Pan, Ying Gao, Liang Chen, Clinical Cancer Research	2011	86
Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells Hongjuan Dong, Liang Chen, Xiequn Chen, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyMedicineApoptosisImmunologyUnfolded Protein Response	2009	66
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia Heng Mei, Xiaofan Liu, Yan Li, Journal of Hematology & Oncology	2021	66
Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells Hongtao Gu, Xiequn Chen, Guangxun Gao, Molecular Cancer Therapeutics	2008	55
Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both<i>In Vitro</i>and<i>In Vivo</i> Xingruo Zeng, Xu Zhou, Jiayan Gu, Molecular Cancer Therapeutics EngineeringTumor BiologyTranscriptional RegulationTranslational BiologyGenitourinary Cancer	2016	46
A Novel Post-translational Modification of Nucleolin, SUMOylation at Lys-294, Mediates Arsenite-induced Cell Death by Regulating gadd45α mRNA Stability Dongyun Zhang, Yuguang Liang, Qipeng Xie, Journal of Biological Chemistry	2015	39
<i>IDH1</i> mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis Yu Gu, Risheng Yang, Ying Yang, Blood	2020	38
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria Lu Zhang, Yujun Dong, Hongling Peng, The Lancet Regional Health - Western Pacific	2023	34
Risk factors for multiple myeloma: A hospital-based case–control study in Northwest China Qixia Wang, Yiwei Wang, Zhaohua Ji, Cancer Epidemiology Hematological MalignancyEpidemiologyCancer RiskGlobal HealthNorthwest China	2012	33

Page 1